滚动资讯
FierceBiotechA new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipelineRoche MediaRoche builds MRD testing arsenal in $595m Saga Diagnostics buyout - Medical Device NetworkLonza NewsLonza Capsugel to Launch UC-FLEX Collagen Blend for Pet Food at Interzoo 2026 - Nutraceutical Business ReviewLonza NewsInterzoo 2026: Lonza Capsugel to unveil pet food collagen blend - Nutrition InsightSchunkMax Rajcic Called Strike to Aaron Schunk - MLB.comAgilentIs Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative (A)? - simplywall.stFierceBiotechSmall pools, big ideas: How the rare disease community is reimagining clinical trialsBrady CorporationBrady India Champions a New Era of Industrial Safety at Safety Conclave 2026 - Machine MakerSchunkMax Rajcic Called Strike to Aaron Schunk - MLB.comSchunkMax Rajcic Called Strike to Aaron Schunk - MLB.comSchunkMax Rajcic Called Strike to Aaron Schunk - MLB.comSchunkMax Rajcic Called Strike to Aaron Schunk - MLB.com
Lonza News 2026年4月7日

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development - Manufacturing Chemist

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development - Manufacturing Chemist

原文
暂时没有全文，请查看原始来源。